GYNECOLOGIC CANCERS

>

Latest News

KEYNOTE-826 Data Supports Pembrolizumab in Patients With Cervical Cancer
KEYNOTE-826 Data Supports Pembrolizumab in Patients With Cervical Cancer

March 10th 2023

Findings from the patient-reported outcomes analysis of the phase 3 KEYNOTE-826 trial support the benefit of pembrolizumab in patients with recurrent, persistent, or metastatic cervical cancer.

Maintenance Niraparib Shows Favorable OS in Platinum-Sensitive Recurrent Ovarian Cancer
Maintenance Niraparib Shows Favorable OS in Platinum-Sensitive Recurrent Ovarian Cancer

March 7th 2023

Availability of FDA-Approved Dual-Stain Triage Test Expands for Cervical Cancer Screenings
Availability of FDA-Approved Dual-Stain Triage Test Expands for Cervical Cancer Screenings

February 10th 2023

Long-Term Follow-Up Shows Olaparib’s Efficacy in Ovarian Cancer
Long-Term Follow-Up Shows Olaparib’s Efficacy in Ovarian Cancer

January 20th 2023

Phase 1 Study Shows Signals of Response With Vaccine for HPV16+ Premalignancies
Phase 1 Study Shows Signals of Response With Vaccine for HPV16+ Premalignancies

December 1st 2022

Video Series
Video Interviews
Podcasts

More News